Delivery Order SPE2DR25D6028-SPE2DR26FARME
- Not listed
- The Defense Logistics Agency awarded a $7,664.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enoxaparin 40 mg/0.4 ml syringes on November 5, 2025, with completion scheduled for November 6, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime vendor contract serves...
- The Defense Logistics Agency awarded a $5,344.44 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Enoxaparin 40 mg/0.4 mL syringes with a completion date of November 10, 2025. This delivery order, issued without set-aside designation, represents a firm fixed price transaction for pharmaceutical products supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $729,981.18 by the Defense Logistics Agency's Medical Supply Chain on November 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,179.36 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, issued on September 4, 2025, represents a child order under a larger indefinite delivery contract (IDC) vehicle and carries an ultimate completion date of September 5, 2025. The award was made through open competition with no set-aside designation, reflecting the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,471.20 by the Defense Logistics Agency's Medical Supply Chain on June 23, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,051.52 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for ultimate completion on July 15,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $782,486.45 by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $152,556.74 by the Defense Logistics Agency's Medical Supply Chain on November 3, 2025, with completion expected by November 4, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,131.09 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain division. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of June 30, 2025. The award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARMEDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for Enoxaparin Injection valued at $2,005.42 by the Defense Logistics Agency (DLA). The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through the established federal procurement process. The delivery order is scheduled for ultimate completion on November 10, 2025, with performance conducted at the contractor's Conshohocken facility. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a prime vendor for federal medical procurement, AmerisourceBergen supplies critical pharmaceutical products and medical supplies to support military and federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio encompasses brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains, with delivery orders ranging from minimal transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/7/25 |